Vertex Spring Co-Op 2027, Combination Device Technologies & Innovation

Role: Vertex offers a 6-month co-op program focused on advancing combination device analytical development within their Cell & Gene Therapy (CGT) division. The position targets MS or PhD students in Chemical Engineering, Physical Chemistry, or related fields, emphasizing hands-on experience with advanced non-destructive analytical techniques (e.g., Raman spectroscopy, UV-Vis, hyperspectral imaging, leak detection) and AI-assisted workflows. Responsibilities include developing and implementing cutting-edge analytical methods for combination products like autoinjectors and cell therapy systems, contributing to digital process automation, and supporting GMP regulatory considerations. Requirements: enrolled in an advanced degree program, strong background in analytical chemistry, instrumentation, and problem-solving skills; experience with spectroscopy and non-destructive testing preferred. High-value: focus on biopharma CGT, combination device characterization, GMP environment, AI integration, and cross-functional collaboration. Work setup: on-site in Boston or Providence, RI, with flexible work arrangements, full-time, paid role, from January to July 2027, with application deadline November 15, 2026.